Search is Powered by Google
Women's Health / Gynecology News

Mirabilis Completes First Human Trial Of Non-Invasive Treatment For Uterine Fibroids

Main Category: Women's Health / Gynecology
Also Included In: Clinical Trials / Drug Trials;  Pregnancy / Obstetrics
Article Date: 01 May 2008 - 1:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:5 stars

5 (1 votes)

Health Professional:not yet rated

Article Opinions: 0 posts

Mirabilis Medica, a privately-held medical device company, announced completion of its first human trial, which served as a preliminary demonstration of clinical feasibility of its prototype High Intensity Focused Ultrasound (HIFU) system for treatment of uterine fibroids. Volunteer patients were treated with the Mirabilis system just prior to scheduled hysterectomies, after which the excised uterine tissue was examined by a pathologist for effects of treatment. This analysis demonstrated successful creation of lesions within the target zone.

"We are encouraged by this early clinical feedback, which is an important milestone in Mirabilis' path to developing a commercial product. We continue to develop several advanced features in preparation for future efficacy studies in patients with fibroids," said Mirabilis CEO Mike Connolly.

About Uterine Fibroids

Fibroids are extremely common benign tumors of the uterus which can substantially impact quality of life. Symptoms can include heavy or prolonged menstrual bleeding, pelvic cramps, urinary frequency or urgency, and pregnancy loss or infertility. An estimated 25% of women (16 million in the U.S.) suffer fibroid symptoms at some point in their life, leading to 250,000 annual U.S. hysterectomies - a highly invasive surgery with many side effects.

About Mirabilis Medica

Mirabilis Medica, based in Bothell WA, was founded in 2004 by Michael Lau, M.D., FACS, FACOG, Alexander Lebedev, and Shahram Vaezy, Ph.D. Mirabilis' patented technology combines the application of therapeutic ultrasound (i.e. HIFU) under real-time guidance of imaging ultrasound. This leading-edge technology is designed to allow a physician to treat pathological tissue deep inside the body without incisions, punctures or other damage to intervening tissue.

Mirabilis Medica




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Diabetes Schizophrenia

customize your homepage

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader

customize your homepage


Vascular Health image Vascular Health

Vascular health refers to the well-being of the heart and the blood vessels. Certain risk factors increase the likelihood that atherosclerosis, a disease of the arteries, will occur. Early detection and knowing your risk factors are keys to improving your health...

Cholesterol Management image Cholesterol Management

Each year more than a million Americans have heart attacks. High cholesterol is a major risk factor for heart attack and stroke. Lifestyle changes and adherence to a treatment plan are important for cholesterol management...

View more videos...